Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.
about
Apigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-κB signaling.Inhibition of MK2 suppresses IL-1β, IL-6, and TNF-α-dependent colorectal cancer growth.Targeting S1P in Inflammatory bowel disease: new avenues for modulating intestinal leukocyte migration.Inflammation and Colorectal Cancer.
P2860
Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Colorectal Cancer and Dysplasi ...... thophysiology, and Management.
@ast
Colorectal Cancer and Dysplasi ...... thophysiology, and Management.
@en
type
label
Colorectal Cancer and Dysplasi ...... thophysiology, and Management.
@ast
Colorectal Cancer and Dysplasi ...... thophysiology, and Management.
@en
prefLabel
Colorectal Cancer and Dysplasi ...... thophysiology, and Management.
@ast
Colorectal Cancer and Dysplasi ...... thophysiology, and Management.
@en
P2093
P2860
P1476
Colorectal Cancer and Dysplasi ...... thophysiology, and Management.
@en
P2093
Parambir S Dulai
Samir Gupta
William J Sandborn
P2860
P304
P356
10.1158/1940-6207.CAPR-16-0124
P577
2016-09-27T00:00:00Z